These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26095184)

  • 1. Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis.
    de Vries EM; Verheij J; Hubscher SG; Leeflang MM; Boonstra K; Beuers U; Ponsioen CY
    J Hepatol; 2015 Nov; 63(5):1212-9. PubMed ID: 26095184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study.
    de Vries EM; de Krijger M; Färkkilä M; Arola J; Schirmacher P; Gotthardt D; Goeppert B; Trivedi PJ; Hirschfield GM; Ytting H; Vainer B; Buuren HR; Biermann K; Harms MH; Chazouilleres O; Wendum D; Kemgang AD; Chapman RW; Wang LM; Williamson KD; Gouw AS; Paradis V; Sempoux C; Beuers U; Hübscher SG; Verheij J; Ponsioen CY
    Hepatology; 2017 Mar; 65(3):907-919. PubMed ID: 27880989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen proportionate area correlates with histological stage and predicts clinical events in primary sclerosing cholangitis.
    Saffioti F; Hall A; de Krijger M; Verheij J; Hübscher SG; Maurice J; Luong TV; Pinzani M; Ponsioen CY; Thorburn D
    Liver Int; 2021 Nov; 41(11):2681-2692. PubMed ID: 34051052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
    Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
    Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.
    de Vries EMG; Färkkilä M; Milkiewicz P; Hov JR; Eksteen B; Thorburn D; Chazouillères O; Pares A; Nygård S; Gilja OH; Wunsch E; Invernizzi P; Carbone M; Bernuzzi F; Boberg KM; Røsjø H; Rosenberg W; Beuers UH; Ponsioen CY; Karlsen TH; Vesterhus M
    Liver Int; 2017 Oct; 37(10):1554-1561. PubMed ID: 28267887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel histological scoring for predicting disease outcome in primary sclerosing cholangitis.
    Sjöblom N; Boyd S; Kautiainen H; Arola J; Färkkilä M
    Histopathology; 2022 Aug; 81(2):192-204. PubMed ID: 35510514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis.
    Vesterhus M; Hov JR; Holm A; Schrumpf E; Nygård S; Godang K; Andersen IM; Naess S; Thorburn D; Saffioti F; Vatn M; Gilja OH; Lund-Johansen F; Syversveen T; Brabrand K; Parés A; Ponsioen CY; Pinzani M; Färkkilä M; Moum B; Ueland T; Røsjø H; Rosenberg W; Boberg KM; Karlsen TH
    Hepatology; 2015 Jul; 62(1):188-97. PubMed ID: 25833813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process.
    Ponsioen CY; Chapman RW; Chazouillères O; Hirschfield GM; Karlsen TH; Lohse AW; Pinzani M; Schrumpf E; Trauner M; Gores GJ
    Hepatology; 2016 Apr; 63(4):1357-67. PubMed ID: 26418478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current policy for allocation of donor livers in the Netherlands advantages primary sclerosing cholangitis patients on the liver transplantation waiting list-a retrospective study.
    Goet JC; Hansen BE; Tieleman M; van Hoek B; van den Berg AP; Polak WG; Dubbeld J; Porte RJ; Konijn-Janssen C; de Man RA; Metselaar HJ; de Vries AC
    Transpl Int; 2018 Jun; 31(6):590-599. PubMed ID: 29150966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel prognostic model for transplant-free survival in primary sclerosing cholangitis.
    de Vries EM; Wang J; Williamson KD; Leeflang MM; Boonstra K; Weersma RK; Beuers U; Chapman RW; Geskus RB; Ponsioen CY
    Gut; 2018 Oct; 67(10):1864-1869. PubMed ID: 28739581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis.
    Goet JC; Floreani A; Verhelst X; Cazzagon N; Perini L; Lammers WJ; de Vries AC; van der Meer AJ; van Buuren HR; Hansen BE
    J Hepatol; 2019 Nov; 71(5):992-999. PubMed ID: 31278949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan.
    Tanaka A; Tazuma S; Nakazawa T; Isayama H; Tsuyuguchi T; Inui K; Takikawa H
    J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):217-225. PubMed ID: 28103424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic extracellular matrix remodeling markers are related to fibrosis stage and prognosis in a phase 2b trial of simtuzumab in patients with primary sclerosing cholangitis.
    Thorburn D; Leeming DJ; Barchuk WT; Wang Y; Lu X; Malkov VA; Ito KL; Bowlus CL; Levy C; Goodman Z; Karsdal MA; Muir AJ; Xu J
    Hepatol Commun; 2024 Jul; 8(7):. PubMed ID: 38967589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver biopsy in primary biliary cholangitis: is sinusoidal fibrosis the missing key?
    Warnes T; Roberts S; Smith A; Haboubi N; McMahon RF
    J Clin Pathol; 2019 Oct; 72(10):669-676. PubMed ID: 31371396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis.
    Keller S; Aigner A; Zenouzi R; Kim AC; Meijer A; Weidemann SA; Krech T; Lohse AW; Adam G; Schramm C; Yamamura J
    PLoS One; 2018; 13(3):e0193929. PubMed ID: 29513767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
    Vesterhus M; Holm A; Hov JR; Nygård S; Schrumpf E; Melum E; Thorbjørnsen LW; Paulsen V; Lundin K; Dale I; Gilja OH; Zweers SJLB; Vatn M; Schaap FG; Jansen PLM; Ueland T; Røsjø H; Moum B; Ponsioen CY; Boberg KM; Färkkilä M; Karlsen TH; Lund-Johansen F
    J Hepatol; 2017 Jun; 66(6):1214-1222. PubMed ID: 28161472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population.
    Ponsioen CY; Vrouenraets SM; Prawirodirdjo W; Rajaram R; Rauws EA; Mulder CJ; Reitsma JB; Heisterkamp SH; Tytgat GN
    Gut; 2002 Oct; 51(4):562-6. PubMed ID: 12235081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis.
    Ehlken H; Wroblewski R; Corpechot C; Arrivé L; Rieger T; Hartl J; Lezius S; Hübener P; Schulze K; Zenouzi R; Sebode M; Peiseler M; Denzer UW; Quaas A; Weiler-Normann C; Lohse AW; Chazouilleres O; Schramm C
    PLoS One; 2016; 11(10):e0164224. PubMed ID: 27723798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis.
    Cazzagon N; Sarcognato S; Floreani A; Corrà G; De Martin S; Guzzardo V; Russo FP; Guido M
    JHEP Rep; 2021 Jun; 3(3):100286. PubMed ID: 34041468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary sclerosing cholangitis: diagnostic performance of MRI compared to blood tests and clinical scoring systems for the evaluation of histopathological severity of disease.
    Song C; Lewis S; Kamath A; Hectors S; Putra J; Kihira S; Bane O; Ahmad J; Babb J; Thung S; Taouli B
    Abdom Radiol (NY); 2020 Feb; 45(2):354-364. PubMed ID: 31844914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.